| Detailed Quote for NPS Pharmaceuticals Inc. (NPSP) |
|
|
|
|
close
52 Week Information
52Wk High
 June 4, 2013
Close:
16.47
52Wk Low
 June 19, 2012
Close:
6.77
|
|
|
|
|
| Change $ |
|---|
0.61
|
|
| Change % |
|---|
3.98%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
News and Media for NPS Pharmaceuticals Inc.
(NPSP)
|
|
|
News for NPSP
|
|
|
|
| 8:00 AM |
Findings Presented at ENDO 2013 Support Therapeutic Potential of Natpara\u00AE as Parathyroid Hormone Replacement Therapy in Patients with Hypoparathyroidism - Business Wire |
| 8:00 AM |
Initial Findings from PARADOX, Largest and Most Comprehensive Research Analyzing the Burden of Hypoparathyroidism, Reveals Collection of Nearly 40 Physical, Cognitive, Emotional Symptoms - Business Wire |
|
|
|
| 1:20 PM |
NPS Pharmaceuticals' President and CEO Dr. Francois Nader Receives Ernst & Young Entrepreneur Of The Year\u00AE 2013 Award in New Jersey - Business Wire |
|
|
|
| 8:11 AM |
NPS Pharmaceuticals to Present Data from Natpara(TM) REPLACE Study and PARADOX Study at ENDO 2013, The Endocrine Society's 95th Annual Meeting - Business Wire |
|
|
|
| 9:00 AM |
NPS Pharmaceuticals Joins the Hypoparathyroidism Association in Recognition of World Hypoparathyroidism Awareness Day - Business Wire |
|
|
|
| 7:58 AM |
Pre-Market Analysis on GILD, NPSP, HALO, SNTS, and ITMN - Accesswire |
|
|
|
| 4:10 PM |
NPS Pharmaceuticals to Present at Jefferies Global Healthcare Conference - Business Wire |
|
|
|
| 4:15 PM |
NPS Pharmaceuticals Announces Exercise of Over-Allotment Option and Closing of Public Offering - Business Wire |
|
|
|
| 4:10 PM |
NPS Pharmaceuticals to Present at Deutsche Bank Health Care Conference - Business Wire |
|
|
|
| 5:57 PM |
NPS Pharmaceuticals Prices Public Offering of Common Stock - Business Wire |
|
|
|
| 4:21 PM |
NPS Pharmaceuticals Announces Proposed Public Offering of 6,000,000 Shares of its Common Stock - Business Wire |
|
|
|
| 8:00 AM |
NPS Pharmaceuticals President and CEO Dr. Francois Nader Recognized as Regional Finalist for Ernst & Young Entrepreneur of the Year\u00AE 2013 - Business Wire |
|
|
|
| 8:15 AM |
NPS Pharmaceuticals Recognized by National Organization for Rare Disorders for Gattex\u00AE as an Innovative Treatment for Patients with Short Bowel Syndrome - Business Wire |
|
|
|
| 8:00 AM |
NPS Pharmaceuticals Reports First Quarter 2013 Financial Results - Business Wire |
|
|
|
| 8:00 AM |
NPS Pharmaceuticals to Report First Quarter 2013 Financial Results - Business Wire |
|
|
|
| 8:00 AM |
NPS Pharmaceuticals Among 100 Best Places to Work in New Jersey for Second Consecutive Year - Business Wire |
|
|
|
| 8:10 AM |
NPS Pharmaceuticals to Present at Needham Healthcare Conference - Business Wire |
|
|
|
| 8:20 AM |
Free Research Reports on MCP, NPSP, SLW and SPPI Issued by the Paragon Report - Marketwired |
|
|
|
| 3:13 PM |
InvestorsGuru.com Filtered Mid-Day Market Movers Recap - Investors Guru |
|
|
|
| 8:00 AM |
Before the Bell Scans of MannKind, Ariad Pharma, ZIOPHARM Oncology, NPS Pharma, and Santarus - PR Newswire |
|
More News for NPSP >> |
|
|
